131833-97-1,
(4R,4'R)-2,2'-(Propane-2,2-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole),
(R,R)-(+)-2,2'-Isopropylidenebis(4-tert-butyl-2-oxazoline),
UNII-A3955GJ8RU,
(R,R)-(-)-2,2'-Isopropylidenebis(4-tert-butyl-2-oxazoline),
A3955GJ8RU,
t-Bu-box, (R,R)-,
(R,R)-t-Bu-box,
(R,R)-t-Bu-box [MI],
(R,R)-t-Bu-box, (+)-,
AC1LELKX,
Bis(oxazoline) ligands (R,R)-t-bu-box [MI],
SCHEMBL247952,
2,2-Bis(4(R)-tert-butyl-1,3-oxazolin-2-yl)propane,
CTK4B7550,
ZINC56894,
DTXSID20350832,
DPMGLJUMNRDNMX-RYUDHWBXSA-N,
(4R)-4-tert-butyl-2-[2-[(4R)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]propan-2-yl]-4,5-dihydro-1,3-oxazole,
5902AA,
ANW-19389,
CI-291,
MFCD07368371,
AKOS015841180,
AKOS015969384,
ACN-047856,
(4R,4'R)-2,2'-(1-Methylethylidene)bis(4-(1,1-dimethylethyl)-4,5-dihydrooxazole),
Oxazole, 2,2'-(1-methylethylidene)bis(4-(1,1-dimethylethyl)-4,5-dihydro-, (4R,4'R)-,
AJ-09490,
AN-32258,
DS-15651,
ZB001873,
TX-011021,
I0795,
C-0642,
833R971,
I14-93311,
2,2'-Isopropylidenebis(4alpha-tert-butyl-2-oxazoline),
(R,R)-2,2'-isopropylidene-bis(4-tert-butyl-2-oxazoline),
(R,R)-2,2'-isopropylidenebis(4-tert-butyl-2-oxazoline),
(R R)-(-)-2 2'-Isopropylidenebis(4-tert-butyl-2-oxazoline),
(R,R)-(+)-2,2-Bis(4-tert-butyl-2-oxazolin-2-yl)propane,
(r,r)-(-)-2,2-isopropylidenebis(4-tert-butyl-2-oxazoline),
RR,R)-(-)-2,2'-isopropylidenebis(4-tert-butyl-2-oxazoline),
(R,R)-(+)-2,2'-(Dimethylmethylene)bis(4-tert-butyl-2-oxazoline),
(4R,4'R)-2,2'-(propane-2,2-diyl)bis(4-tert-butyl-4,5-dihydrooxazole),
(4R,4'R)-2,2'-(Propane-2,2-diyl)bis(4-tert-butyl-4,5-dihydro-1,3-oxazole),
(4R)-4-tert-butyl-2-[1-[(4R)-4-tert-butyl-4,5-dihydrooxazol-2-yl]-1-methyl-ethyl]-4,5-dihydrooxazole,
C17H30N2O2,
CID688210,
NSC648469,
(S,S)-(-)-2,2'-Isopropylidenebis(4-tert-butyl-2-oxazoline),
131833-93-7,
(R,R)-( )-2,2'-Isopropylidenebis(4-tert-butyl-2-oxazoline), 98% - 250MG 250mg,